Cevidoplenib | Interleukin Related interleukin-related.com

Product Name :
Cevidoplenib

Search keywords :
Cevidoplenib

drugId :
null

Target Vo:
Spleen tyrosine kinase

Target Vo Short Name :
Syk

Moa_Name:
Spleen tyrosine kinase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Oscotec Inc

Active Company_Name :
Oscotec Inc

Active Indication_Name:
Purpura, Thrombocytopenic, Idiopathic

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HDAC2 Rabbit mAb web
Cadonilimab Epigenetics
Bad Antibody: Bad Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to Bad. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts